REVIEW PAPER
Ellagic acid: an alternative for antifungal drugs resistance in HIV/AIDS patients with oropharyngeal candidiasis
1
Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
2
Dental and Biomaterial Research Group, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
3
Department of Oral Medicine, Faculty of Dental Medicine, Universitas Airlangga, Surabaya, Indonesia
Submission date: 2019-07-09
Final revision date: 2019-08-20
Acceptance date: 2019-08-28
Publication date: 2020-10-02
HIV & AIDS Review 2020;19(3):153-156
KEYWORDS
TOPICS
ABSTRACT
Oropharyngeal candidiasis (OPC) is considered the most common fungal infection in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients. Antifungal drug, azole group, is the preferred treatment. However, the long-term use of antifungal drug as prophylaxis and therapy for OPC may lead to a compromised side effects and drug resistance. Nowadays, the prevalence of antifungal Candida albicans resistance is approximately 56.7%. Ellagic acid (EA) presents broad spectrum of antifungal activities. Based on previous studies, EA can act as natural antifungal agent. It also helps enhancing oral mucosal innate immunity. This review explores the antifungal activity of EA as an alternative for antifungal drugs resistance in HIV/AIDS patients with OPC. A web-based search was conducted via PubMed, NCBI, Scopus, ScienceDirect, and ResearchGate databases, with “antifungal resistance”, “ellagic acid”, “HIV/AIDS”, and “OPC” as the keywords. EA is a dimeric derivative of gallic acid that is found in several plants. EA can induce the expression of hBD2 and SLPI in the oral mucosa. Those proteins play a pivotal role in immunomodulation and anti-inflammation of oral microenvironment innate immunity, which inhibit several opportunistic pathogens and microbes, including Candida. Furthermore, EA also inhibits ergosterol biosynthesis (EB), which is the primary component of fungi cell membrane. EA breakdown fungal membrane permeability and enzyme activity, leading to cessation of fungal growth. EA presents antifungal activity in HIV/AIDS patients with OPC; thus, it can be used as an alternative in antifungal drug resistance.
REFERENCES (25)
1.
Joint United Nations. Programme on HIV/AIDS (UNAIDS). Overview HIV/AIDS Infection in Indonesia. Joint United Nations; 2016. Available from: http://www.unaids.org/en/regio... (Accessed: 21.01.2019).
2.
Avert Organization Global Information and Education on HIV and AIDS. HIV and AIDS in Asia & The Pasific Regional Overview. Available from: https://www.avert.org/professi... (Accessed: 1.04.2019).
3.
Mensana MP, Ernawati DS, Nugraha AP, Soebadi B, Triyono EA, Husada D. Oral candidiasis profile of the Indonesian HIV-infected pediatric patients at UPIPI Dr. Soetomo General Hospital, Surabaya, Indonesia. HIV AIDS Rev 2018; 17: 272-277.
4.
Mensana MP, Nugraha AP, Ernawati DS, Soebadi B, Triyono EA, Husada D. Sensitivity and specificity of linear gingival erythema as immune suppression marker in pediatric HIV‐infected at UPIPI soetomo general hospital Surabaya, Indonesia. Indian J Public Health Res Dev 2019; 10: 575-580.
5.
Directorate of Prevention and Disease Control, Republic of Indonesia Health Ministry. Progress Report Situation of HIV/AIDS in Indonesia. Directorate of Prevention and Disease Control; 2017. Available from: http://siha.depkes.go.id/porta... (Accessed: 1.04.2019).
6.
Nugraha AP, Ernawati DS, Parmadiati AE, Soebadi B, Triyono EA, Prasetyo RA. Prevalence of Candida species in oral candidiasis and correlation with CD4+count in HIV/AIDS patients at Surabaya, Indonesia. J Int Dent Med Res 2018; 11: 81‐85.
7.
Parmadiati AE, Ernawati DS, Soebadi B, Nugraha AP, Triyono EA, Prasetyo RA. Correlation oral hairy leukoplakia and CD4+ counts in HIV/AIDS patients at Dr. Soetomo hospital Surabaya, Indonesia 2014. J Int Dent Med Res 2017; 10: 162‐165.
8.
Mensana MP, Nugraha AP, Ernawati DS, Triyono EA, Husada D, Prasetyo RA. Correlation of oral hairy leukoplakia, HAART and CD4+ in HIV-infected pediatric patients at UPIPI Soetomo Hospital Surabaya, Indonesia. J Int Dent Med Res 2019; 12: 165-169.
9.
Nugraha AP, Ernawati DS, Parmadiati EA, Soebadi B, Triyono EA, Prasetyo RA. Correlation linear gingival erythema, Candida infection and CD4+ counts in HIV/AIDS patients at UPIPI RSUD Dr. Soetomo Surabaya, East Java, Indonesia. J Int Dent Med Res 2017; 10: 322-326.
10.
Nugraha AP, Triyono EA, Prahasanti C, Sufiawati I, Prasetyo RA, Ernawati DS. The correlation of pathognomonic periodontal manifestation with CD4+ level in people live with human immunodeficiency virus/acquired immunodeficiency syndrome in a Tertiary Hospital, Surabaya, Indonesia. J Int Oral Health 2019; 11: 137-140.
11.
Nugraha AP, Ernawati DS, Harijanti K, Parmadiati AE. Psychological stress induced xerostomia and hyposalivation: the case study in Indonesian female patient. J Int Dent Med Res 2019; 12: 216-219.
12.
Nizamuddin I, Koulen P, McArthur C. Contribution of HIV infection, AIDS, and antiretroviral therapy to exocrine pathogenesis in salivary and lacrimal glands. J Int Mol Sci 2018; 19: 2747.
13.
Nittayananta W. Oral fungi in HIV: challenges in antifungal therapies. Oral Dis 2016; 22 Suppl 1: 107-113.
14.
Osaigbovo I, Lofor PV, Oladele RO. Fluconazole resistance among oral Candida isolates from people living with HIV/AIDS in a Nigeria Tertiary Hospital. J Fungi (Basel) 2017; 3: 69.
15.
Promsong A, Chung WO, Satthakarn S, Nittayananta W. Ellagic acid modulates the expression oral innate immune mediators: potential role in mucosal protection. J Oral Pathol Med 2015; 44: 214-221.
16.
Patil S, Majumdar B, Sarode S, Sarode G, Awan K. Oropharyngeal candidiasis in HIV-infected patients – an update. Front Microbiol 2018; 9: 980.
17.
Nugraha AP, Ernawati DS, Parmadiati AE, Soebadi B, Prasetyo RA, Triyono EA. Study of drug utilization within an anti‐fungal therapy for HIV/AIDS patients presenting oral candidiasis at UPIPI RSUD, Dr. Soetomo hospital, Surabaya. J Int Dent Med Res 2018; 11: 131-134.
18.
Perlin D, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 2017; 17: e383-e392.
19.
Sobel JD, Akins RA. The role of resistance in Candida infections: epidemiology and treatment. In: Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects. Volume 2, 2017; 1075-1097.
20.
Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans candida species. Front Microbiol 2017; 7: 2173.
21.
Salari S, Khosravi AR, Mousavi SA, Nikbakht-Brojeni GH. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis. J Mycol Med 2016; 26: 35-41.
22.
Menaa F, Menaa A. Skin photoprotection by polyphenols in animal models and humans. Polyphenols in Human Health and Disease 2014; 831-838.
23.
Usta C, Ozdemir S, Schiariti M, Puddu P. The pharmacological use of ellagic acid-rich pomegranate fruit. Int J Food Sci Nutr 2013; 64: 907-913.
24.
Nittayananta W, Tao R, Jiang L, Peng Y, Huang Y. Oral innate immunity in HIV infection in HAART era. J Oral Pathol Med 2016; 45: 3-8.
25.
Li Z, Guo X, Dawuti G, Aibai S. Antifungal activity of ellagic acid in vitro and in vivo. Phytotherapy Res 2014; 29: 1019-1025.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
